<p>Deep generative models are used to generate arbitrary molecular structures with the desired chemical properties. MolGAN is a renowned molecular generation models that uses generative adversarial networks (GANs) and reinforcement learning to generate molecular graphs in one shot. MolGAN can effectively generate a small molecular graph with nine or fewer heavy atoms. However, the graphs tend to become disconnected as the molecular size increase. This poses a challenge to drug discovery and material design, where large molecules are potentially inclusive. This study develops an improved MolGAN for large molecule generation (L-MolGAN). In this model, the connectivity of molecular graphs is evaluated by a depth-first search during the model training process. When a disconnected molecular graph is generated, L-MolGAN rewards the graph a zero score. This procedure decreases the number of disconnected graphs, and consequently increases the number of connected molecular graphs. The effectiveness of L-MolGAN is experimentally evaluated. The size and connectivity of the molecular graphs generated with data from the ZINC-250k molecular dataset are confirmed using MolGAN as the baseline model. The model is then optimized for a quantitative estimate of drug-likeness (QED) to generate drug-like molecules. The experimental results indicate that the connectivity measure of generated molecular graphs improved by 1.96 compared with the baseline model at a larger maximum molecular size of 20 atoms. The molecules generated by L-MolGAN are evaluated in terms of multiple chemical properties, QED, synthetic accessibility, and log octanol–water partition coefficient, which are important in drug design. This result confirms that L-MolGAN can generate various drug-like molecules despite being optimized for a single property, i.e., QED. This method will contribute to the efficient discovery of new molecules of larger sizes than those being generated with the existing method.<br></p>
<p>Deep generative models are used to generate arbitrary molecular structures with the desired chemical properties. MolGAN is a renowned molecular generation models that uses generative adversarial networks (GANs) and reinforcement learning to generate molecular graphs in one shot. MolGAN can effectively generate a small molecular graph with nine or fewer heavy atoms. However, the graphs tend to become disconnected as the molecular size increase. This poses a challenge to drug discovery and material design, where large molecules are potentially inclusive. This study develops an improved MolGAN for large molecule generation (L-MolGAN). In this model, the connectivity of molecular graphs is evaluated by a depth-first search during the model training process. When a disconnected molecular graph is generated, L-MolGAN rewards the graph a zero score. This procedure decreases the number of disconnected graphs, and consequently increases the number of connected molecular graphs. The effectiveness of L-MolGAN is experimentally evaluated. The size and connectivity of the molecular graphs generated with data from the ZINC-250k molecular dataset are confirmed using MolGAN as the baseline model. The model is then optimized for a quantitative estimate of drug-likeness (QED) to generate drug-like molecules. The experimental results indicate that the connectivity measure of generated molecular graphs improved by 1.96 compared with the baseline model at a larger maximum molecular size of 20 atoms. The molecules generated by L-MolGAN are evaluated in terms of multiple chemical properties, QED, synthetic accessibility, and log octanol–water partition coefficient, which are important in drug design. This result confirms that L-MolGAN can generate various drug-like molecules despite being optimized for a single property, i.e., QED. This method will contribute to the efficient discovery of new molecules of larger sizes than those being generated with the existing method.<br></p>
<p>Deep generative models are used to generate arbitrary molecular structures with the desired chemical properties. MolGAN is a renowned molecular generation models that uses generative adversarial networks (GANs) and reinforcement learning to generate molecular graphs in one shot. MolGAN can effectively generate a small molecular graph with nine or fewer heavy atoms. However, the graphs tend to become disconnected as the molecular size increase. This poses a challenge to drug discovery and material design, where large molecules are potentially inclusive. This study develops an improved MolGAN for large molecule generation (L-MolGAN). In this model, the connectivity of molecular graphs is evaluated by a depth-first search during the model training process. When a disconnected molecular graph is generated, L-MolGAN rewards the graph a zero score. This procedure decreases the number of disconnected graphs, and consequently increases the number of connected molecular graphs. The effectiveness of L-MolGAN is experimentally evaluated. The size and connectivity of the molecular graphs generated with data from the ZINC-250k molecular dataset are confirmed using MolGAN as the baseline model. The model is then optimized for a quantitative estimate of drug-likeness (QED) to generate drug-like molecules. The experimental results indicate that the connectivity measure of generated molecular graphs improved by 1.96 compared with the baseline model at a larger maximum molecular size of 20 atoms. The molecules generated by L-MolGAN are evaluated in terms of multiple chemical properties, QED, synthetic accessibility, and log octanol–water partition coefficient, which are important in drug design. This result confirms that L-MolGAN can generate various drug-like molecules despite being optimized for a single property, i.e., QED. This method will contribute to the efficient discovery of new molecules of larger sizes than those being generated with the existing method.<br></p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.